Kappa free light chains is a valid tool in the diagnostics of MS A large multicenter study /
To validate kappa free light chain (KFLC) and lambda free light chain (LFLC) indices as a diagnostic biomarker in multiple sclerosis (MS).We performed a multicenter study including 745 patients from 18 centers (219 controls and 526 clinically isolated syndrome (CIS)/MS patients) with a known oligocl...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2020
|
| Sorozat: | MULTIPLE SCLEROSIS JOURNAL
26 No. 8 |
| Tárgyszavak: | |
| doi: | 10.1177/1352458519845844 |
| mtmt: | 31040420 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/24521 |